Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Orphanet Journal of Rare Diseases
|
April 11, 2023
Decentralized clinical trials and rare diseases: a Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) perspective
Mercedeh Ghadessi, Junrui Di, Chenkun Wang, et al.
Orphanet Journal of Rare Diseases
|
March 14, 2020
A roadmap to using historical controls in clinical trials - by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG)
Mercedeh Ghadessi, Rui Tang, Joey Zhou, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 10, 2013
Whole-transcriptome profiling of thyroid nodules identifies expression-based signatures for accurate thyroid cancer diagnosis
Sam M Wiseman, Zaid Haddad, Blair Walker, et al.
Therapeutic Innovation & Regulatory Science
|
August 8, 2025
Insights on Clinical Development of Cell and Gene Therapy for Rare Diseases-by DahShu Innovative Design Scientific Working Group (IDSWG)
Chenkun Wang, Junrui Di, Mercedeh Ghadessi, et al.
BJU International
|
March 13, 2015
Clinical and genomic analysis of metastatic prostate cancer progression with a background of postoperative biochemical recurrence
Mohammed Alshalalfa, Anamaria Crisan, Ismael A Vergara, et al.
European Urology
|
April 30, 2015
Utility of Risk Models in Decision Making After Radical Prostatectomy: Lessons from a Natural History Cohort of Intermediate- and High-Risk Men
Ashley E Ross, Kasra Yousefi, Elai Davicioni, et al.
Journal of the National Cancer Institute
|
October 26, 2014
Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer
Anirban P Mitra, Lucia L Lam, Mercedeh Ghadessi, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 19, 2014
Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy
Robert B Den, Felix Y Feng, Timothy N Showalter, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 29, 2012
Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome
Paula J Hurley, Luigi Marchionni, Brian W Simons, et al.
Plos One
|
July 5, 2013
Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy
Nicholas Erho, Anamaria Crisan, Ismael A Vergara, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Orphanet Journal of Rare Diseases
|
April 11, 2023
Decentralized clinical trials and rare diseases: a Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) perspective
Mercedeh Ghadessi, Junrui Di, Chenkun Wang, et al.
Orphanet Journal of Rare Diseases
|
March 14, 2020
A roadmap to using historical controls in clinical trials - by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG)
Mercedeh Ghadessi, Rui Tang, Joey Zhou, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 10, 2013
Whole-transcriptome profiling of thyroid nodules identifies expression-based signatures for accurate thyroid cancer diagnosis
Sam M Wiseman, Zaid Haddad, Blair Walker, et al.
Therapeutic Innovation & Regulatory Science
|
August 8, 2025
Insights on Clinical Development of Cell and Gene Therapy for Rare Diseases-by DahShu Innovative Design Scientific Working Group (IDSWG)
Chenkun Wang, Junrui Di, Mercedeh Ghadessi, et al.
BJU International
|
March 13, 2015
Clinical and genomic analysis of metastatic prostate cancer progression with a background of postoperative biochemical recurrence
Mohammed Alshalalfa, Anamaria Crisan, Ismael A Vergara, et al.
European Urology
|
April 30, 2015
Utility of Risk Models in Decision Making After Radical Prostatectomy: Lessons from a Natural History Cohort of Intermediate- and High-Risk Men
Ashley E Ross, Kasra Yousefi, Elai Davicioni, et al.
Journal of the National Cancer Institute
|
October 26, 2014
Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer
Anirban P Mitra, Lucia L Lam, Mercedeh Ghadessi, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 19, 2014
Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy
Robert B Den, Felix Y Feng, Timothy N Showalter, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 29, 2012
Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome
Paula J Hurley, Luigi Marchionni, Brian W Simons, et al.
Plos One
|
July 5, 2013
Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy
Nicholas Erho, Anamaria Crisan, Ismael A Vergara, et al.
Page
of 3